Immunitybio to participate in the jefferies london healthcare conference

Culver city, calif.--(business wire)--immunotherapy innovator immunitybio, inc. (nasdaq: ibrx), announced today that company executives will be participating in the jefferies london healthcare conference, which is taking place november 19-21 at the waldorf hilton london. details of the presentation can be found below. jefferies london healthcare conference date: tuesday, november 19, 2024 time: 2:30 pm gt format: fireside chat with immunitybio company executives a replay of the recorded firesid.
IBRX Ratings Summary
IBRX Quant Ranking